title: Yap1 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin.
abstract: The Hippo-Yap (Yes-associated protein) signaling pathway has emerged as one of the critical pathways regulating cell proliferation, differentiation, and apoptosis in response to environmental and developmental cues. However, Yap1 roles in vascular smooth muscle cell (VSMC) biology have not been investigated. VSMCs undergo phenotypic switch, a process characterized by decreased gene expression of VSMC contractile markers and increased proliferation, migration, and matrix synthesis. The goals of the present studies were to investigate the relationship between Yap1 and VSMC phenotypic switch and to determine the molecular mechanisms by which Yap1 affects this essential process in VSMC biology. Results demonstrated that the expression of Yap1 was rapidly up-regulated by stimulation with PDGF-BB (a known inducer of phenotypic switch in VSMCs) and in the injured vessel wall. Knockdown of Yap1 impaired VSMC proliferation in vitro and enhanced the expression of VSMC contractile genes as well by increasing serum response factor binding to CArG-containing regions of VSMC-specific contractile genes within intact chromatin. Conversely, the interaction between serum response factor and its co-activator myocardin was reduced by overexpression of Yap1 in a dose-dependent manner. Taken together, these results indicate that down-regulation of Yap1 promotes VSMC contractile phenotype by both up-regulating myocardin expression and promoting the association of the serum response factor-myocardin complex with VSMC contractile gene promoters and suggest that the Yap1 signaling pathway is a central regulator of phenotypic switch of VSMCs.
authors.affiliation: Cardiovascular Center, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.
authors.forename: Changqing
authors.initials: C
authors.lastname: Xie
authors.forename: Yanhong
authors.initials: Y
authors.lastname: Guo
authors.forename: Tianqing
authors.initials: T
authors.lastname: Zhu
authors.forename: Jifeng
authors.initials: J
authors.lastname: Zhang
authors.forename: Peter X
authors.initials: PX
authors.lastname: Ma
authors.forename: Y Eugene
authors.initials: YE
authors.lastname: Chen
mesh_terms: D000818:Animals; D051017:Apoptosis Regulatory Proteins / Q000096:biosynthesis* / Q000235:genetics; D000077214:Becaplermin; D002465:Cell Movement / Q000502:physiology; D049109:Cell Proliferation; D005786:Gene Expression Regulation / Q000502:physiology*; D055785:Gene Knockdown Techniques; D057809:HEK293 Cells; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000378:metabolism*; D032389:Myocytes, Smooth Muscle / Q000166:cytology / Q000378:metabolism*; D009687:Nuclear Proteins / Q000096:biosynthesis* / Q000235:genetics; D020574:Proto-Oncogene Proteins c-sis / Q000235:genetics / Q000378:metabolism; D051381:Rats; D015534:Trans-Activators / Q000096:biosynthesis* / Q000235:genetics; D000091102:YAP-Signaling Proteins; D000099251:Myocardin
chemical_list: D051017:Apoptosis Regulatory Proteins; D000077214:Becaplermin; D009687:Nuclear Proteins; D020574:Proto-Oncogene Proteins c-sis; D015534:Trans-Activators; D000091102:YAP-Signaling Proteins; D000099251:Myocardin; C509425:Yap1 protein, rat